This inventor holds 4 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Sumitomo Dainippon Pharma Co., Ltd., Sumitomo Pharma Co., Ltd., The Kitasato Institute. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Shunichiro Uesugi: Innovator in Medicinal Chemistry
Introduction
Shunichiro Uesugi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 4 patents, Uesugi's work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Uesugi's latest patents include a cycloalkylurea derivative, which serves as a medicament for treating or preventing diseases related to the orexin receptor, especially orexin type 2 receptor. This invention is particularly relevant for conditions such as narcolepsy, idiopathic hypersomnia, hypersomnia, and sleep apnea syndrome. Another notable patent is for an oxo-substituted compound that exhibits an excellent β-lactamase inhibitory effect. This compound can be used alone or in combination with β-lactam drugs to create effective preventive or therapeutic agents for bacterial infections.
Career Highlights
Throughout his career, Uesugi has worked with reputable organizations, including Sumitomo Pharma Co., Ltd. and The Kitasato Institute. His experience in these institutions has allowed him to refine his expertise in drug development and medicinal chemistry.
Collaborations
Uesugi has collaborated with notable colleagues such as Eiji Ideue and Masafumi Komiya. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Shunichiro Uesugi's innovative work in medicinal chemistry has led to the development of important therapeutic agents. His contributions continue to impact the field and improve health outcomes for patients worldwide.